Acquired by Oracle in June 2022
CERN - Cerner Corporation
NASDAQ
->
Healthcare
->
Health Information Services
North Kansas City,
United States
Type: Equity
CERN price evolution
CERN
| (in millions $) | 31 Mar 2022 | 31 Dec 2021 | 30 Sep 2021 | 30 Jun 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $709.53 | $589.85 | $459.54 | $246.4 |
| Short term investments | $171.18 | $252.62 | $322.63 | $638.49 |
| Net receivables | $1178.04 | $1161.36 | $1219.85 | $1237.23 |
| Inventory | $27.7 | $28.16 | $25.39 | $20.17 |
| Total current assets | $2467.86 | $2449.45 | $2440.16 | $2540.8 |
| Long term investments | $456.4 | $461.98 | $488.45 | $497.35 |
| Property, plant & equipment | $1686.97 | $1739.11 | $1807.25 | $1864.28 |
| Goodwill & intangible assets | $2568.24 | $2589.96 | $2611.35 | $2623.69 |
| Total noncurrent assets | $4906.37 | $4984.7 | $5103 | $5180.3 |
| Total investments | $627.58 | $714.61 | $811.09 | $1135.84 |
| Total assets | $7374.23 | $7434.16 | $7543.16 | $7721.1 |
| Current liabilities | ||||
| Accounts payable | $359.56 | $329.58 | $311.2 | $332.96 |
| Deferred revenue | $456.93 | $531.23 | $438.06 | $429.22 |
| Short long term debt | $225 | $225 | $225 | |
| Total current liabilities | $1378.87 | $1626.26 | $1551.33 | $1542.89 |
| Long term debt | $1611.3 | $1611.26 | $1611.2 | $1611.15 |
| Total noncurrent liabilities | $2086.84 | $2127.44 | $2151.93 | $2151.72 |
| Total debt | $1611.3 | $1836.26 | $1836.2 | $1836.15 |
| Total liabilities | $3465.71 | $3753.7 | $3703.26 | $3694.62 |
| Shareholders' equity | ||||
| Retained earnings | $6877.11 | $6751.69 | $6656.68 | $6546.61 |
| Other shareholder equity | -$119.3 | -$127.56 | -$129.7 | -$118.73 |
| Total shareholder equity | $3908.52 | $3680.46 | $3839.9 | $4026.48 |
| (in millions $) | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 | 31 Dec 2018 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $589.85 | $615.62 | $441.84 | $374.13 |
| Short term investments | $252.62 | $442.47 | $99.93 | $401.29 |
| Net receivables | $1161.36 | $1168.71 | $1139.6 | $1183.49 |
| Inventory | $28.16 | $23.03 | $23.18 | $25.03 |
| Total current assets | $2449.45 | $2650.99 | $2096.62 | $2318.8 |
| Long term investments | $461.98 | $510.22 | $419.42 | $300.05 |
| Property, plant & equipment | $1739.11 | $1908.62 | $1981.93 | $1743.58 |
| Goodwill & intangible assets | $2589.96 | $2253.12 | $2187.46 | $2147.36 |
| Total noncurrent assets | $4984.7 | $4870.11 | $4798 | $4389.83 |
| Total investments | $714.61 | $952.69 | $519.35 | $701.33 |
| Total assets | $7434.16 | $7521.1 | $6894.62 | $6708.64 |
| Current liabilities | ||||
| Accounts payable | $329.58 | $235.75 | $273.44 | $293.53 |
| Deferred revenue | $531.23 | $393.29 | $360.02 | $399.19 |
| Short long term debt | $225 | $4.91 | ||
| Total current liabilities | $1626.26 | $1168.63 | $1027.45 | $962.69 |
| Long term debt | $1611.26 | $1336.07 | $1038.38 | $438.8 |
| Total noncurrent liabilities | $2127.44 | $1869.9 | $1549.85 | $817.56 |
| Total debt | $1836.26 | $1336.07 | $1038.38 | $443.72 |
| Total liabilities | $3753.7 | $3038.53 | $2577.29 | $1780.25 |
| Shareholders' equity | ||||
| Retained earnings | $6751.69 | $6475.55 | $5934.91 | $5576.52 |
| Other shareholder equity | -$127.56 | -$120.8 | -$118.66 | -$103.55 |
| Total shareholder equity | $3680.46 | $4482.57 | $4317.33 | $4928.39 |
| (in millions $) | 31 Mar 2022 | 31 Dec 2021 | 30 Oct 2021 | 30 Jul 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1429.8 | $1452.32 | $1456.76 | |
| Cost of revenue | $243.85 | $257.93 | $261.32 | |
| Gross Profit | $1185.95 | $1194.39 | $1195.43 | |
| Operating activities | ||||
| Research & development | $195.09 | $199.41 | $241.6 | |
| Selling, general & administrative | $722.28 | $762.54 | $887.38 | |
| Total operating expenses | $933.97 | $978.65 | $1145.87 | |
| Operating income | $251.98 | $215.74 | $49.56 | |
| Income from continuing operations | ||||
| EBIT | $252.01 | $212.46 | $47.88 | |
| Income tax expense | $45.88 | $37.62 | $15.18 | |
| Interest expense | ||||
| Net income | ||||
| Net income | $206.13 | $174.84 | $32.71 | |
| Income (for common shares) | $206.13 | $174.84 | $32.71 | |
| (in millions $) | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 | 31 Dec 2018 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $5764.82 | $5505.79 | $5692.6 | $5366.32 |
| Cost of revenue | $1001.02 | $932.94 | $1071.04 | $937.35 |
| Gross Profit | $4763.81 | $4572.85 | $4621.56 | $4428.98 |
| Operating activities | ||||
| Research & development | $836 | $749.01 | $737.14 | $683.66 |
| Selling, general & administrative | $3156.87 | $3074.2 | $3195.93 | $2883.16 |
| Total operating expenses | $4055.53 | $3658.28 | $4020.89 | $3654.19 |
| Operating income | $708.28 | $914.57 | $600.67 | $774.78 |
| Income from continuing operations | ||||
| EBIT | $699.46 | $991.47 | $654.51 | $800.85 |
| Income tax expense | $143.86 | $211.38 | $125.06 | $170.79 |
| Interest expense | ||||
| Net income | ||||
| Net income | $555.6 | $780.09 | $529.45 | $630.06 |
| Income (for common shares) | $555.6 | $780.09 | $529.45 | $630.06 |
| (in millions $) | 31 Mar 2022 | 31 Dec 2021 | 30 Sep 2021 | 30 Jun 2021 |
|---|---|---|---|---|
| Net income | $206.13 | $174.84 | $175.79 | $32.71 |
| Operating activities | ||||
| Depreciation | $175.22 | $183.04 | $181.25 | $179.25 |
| Business acquisitions & disposals | -$7.33 | $1.69 | -$349.87 | |
| Stock-based compensation | $33.33 | $38.49 | $55.27 | $53.94 |
| Total cash flows from operations | $375.06 | $517.29 | $434.82 | $369.13 |
| Investing activities | ||||
| Capital expenditures | -$98.69 | -$108.23 | -$113.75 | -$206.91 |
| Investments | $91.2 | $97.64 | $324.49 | -$163.79 |
| Total cash flows from investing | -$12.2 | -$24.27 | $205.26 | -$728.63 |
| Financing activities | ||||
| Dividends paid | -$79.18 | -$65.42 | -$66.79 | -$67.78 |
| Sale and purchase of stock | $63.39 | -$285.5 | -$315.32 | -$289.9 |
| Net borrowings | -$225 | |||
| Total cash flows from financing | -$241.33 | -$361.77 | -$417.7 | -$392.49 |
| Effect of exchange rate | -$1.85 | -$0.94 | -$9.24 | $0.54 |
| Change in cash and equivalents | $119.69 | $130.31 | $213.14 | -$751.46 |
| (in millions $) | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 | 31 Dec 2018 |
|---|---|---|---|---|
| Net income | $555.6 | $780.09 | $529.45 | $630.06 |
| Operating activities | ||||
| Depreciation | $718.85 | $697.42 | $687.97 | $642.59 |
| Business acquisitions & disposals | -$355.5 | $179.65 | -$74.54 | |
| Stock-based compensation | $195.65 | $153.45 | $103.64 | $95.42 |
| Total cash flows from operations | $1771.68 | $1436.7 | $1313.1 | $1454.01 |
| Investing activities | ||||
| Capital expenditures | -$588.37 | -$579.26 | -$745.39 | -$720.62 |
| Investments | $243.6 | -$363.39 | $215.11 | -$71.5 |
| Total cash flows from investing | -$729.83 | -$801.24 | -$640.41 | -$828.94 |
| Financing activities | ||||
| Dividends paid | -$267.48 | -$221.46 | -$113.82 | |
| Sale and purchase of stock | -$1195.92 | -$503.35 | -$1062.51 | -$531.78 |
| Net borrowings | $500 | $297.5 | $600 | -$75 |
| Total cash flows from financing | -$1054.85 | -$461.5 | -$601.38 | -$609.79 |
| Effect of exchange rate | -$12.77 | -$0.2 | -$3.59 | -$12.08 |
| Change in cash and equivalents | -$25.77 | $173.77 | $67.72 | $3.2 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 293.97M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | 3.03% |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | 0.00 |
| Book/Share | 13.70 |
| Cash/Share | 2.41 |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 1.02 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.79 |
| Quick ratio | 1.77 |